A Study of Perioperative Intravenous Lidocaine Infusion for Patients Undergoing Laparoscopic and Open Pancreatectomies

Overview

About this study

The purpose of this study is to evaluate if a lidocaine infusion during surgery will provide benefit to pancreatectomy patients in regards to analgesia and return of bowel function.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria

  • All adult patients undergoing elective open or laparoscopic total pancreatectomies and pancreatoduodenectomies (i.e., Whipple procedure), and participating in the Enhanced Recovery Protocol (ERP) at Mayo Clinic in Florida
  • Age 18 - 80 years old
  • American Society of Anesthesiologist (ASA) class I - III
  • BMI < 40
  • Ability to understand and read English

 

Exclusion Criteria

  • Not able or willing to sign consent
  • Intolerance or allergy to opioids, NSAIDS, acetaminophen, or amide-type local anesthetics (i.e., lidocaine)
  • History of epilepsy or currently receiving treatment for seizures
  • Severe hepatic insufficiency (Child-Pugh Score C)
  • Renal insufficiency (creatinine clearance less than 30 mL/minute)
  • Advanced heart failure (NY Heart failure stage 3 or greater; Ejection function <30%)
  • Cardiac arrhythmias
    • 2nd and 3rd degree heart block
    • Sick sinus syndrome
    • Symptomatic bradyarrhythmias
    • Wolff-Parkinson-White (WPW) syndrome
    • Stokes-Adams syndrome
    • Left bundle branch block
    • Bifascicular block
    • Not excluding patients with the following conditions unless clinical circumstances dictate
      • Atrial fibrillation or atrial flutter
      • Presence of Implantable Cardioverter Defibrillator (ICD), or pacemakers
  • On anti-arrhythmic therapy i.e.
    • Digoxin
    • Amiodarone
    • Flecainide
    • Lidocaine
    • Sotalol
    • Etc
    • Not excluding patients on beta blockers i.e. metoprolol, atenolol, etc. unless clinical circumstance dictate
  • Active psychiatric disorders or cognitive dysfunction
  • Pregnancy or lactating
  • Enucleation, central, and distal pancreatectomy
  • Opioid tolerance (defined as consumption of greater than 30 mg of oxycodone per day)

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status

Jacksonville, Fla.

Mayo Clinic principal investigator

Elird Bojaxhi, M.D.

Closed for enrollment

More information

Publications

Publications are currently not available
.
CLS-20169967

Mayo Clinic Footer